BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

954 related articles for article (PubMed ID: 23290325)

  • 21. A downscaled practical measure of mood lability as a screening tool for bipolar II.
    Benazzi F; Akiskal HS
    J Affect Disord; 2005 Feb; 84(2-3):225-32. PubMed ID: 15708420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder.
    Miller CJ; Klugman J; Berv DA; Rosenquist KJ; Ghaemi SN
    J Affect Disord; 2004 Aug; 81(2):167-71. PubMed ID: 15306144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for bipolar disorder: the utility and comparative properties of the MSS and MDQ measures.
    Parker G; Fletcher K; Barrett M; Synnott H; Breakspear M; Hyett M; Hadzi-Pavlovic D
    J Affect Disord; 2008 Jul; 109(1-2):83-9. PubMed ID: 18082895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between self-reported anxiety symptoms and suicidality.
    Diefenbach GJ; Woolley SB; Goethe JW
    J Nerv Ment Dis; 2009 Feb; 197(2):92-7. PubMed ID: 19214043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.
    Angst J; Azorin JM; Bowden CL; Perugi G; Vieta E; Gamma A; Young AH;
    Arch Gen Psychiatry; 2011 Aug; 68(8):791-8. PubMed ID: 21810644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prediction rule for diagnosing hypomania.
    Benazzi F
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):317-22. PubMed ID: 19141309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicians' assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients.
    Comtois KA; Russo JE; Roy-Byrne P; Ries RK
    Biol Psychiatry; 2004 Nov; 56(10):757-63. PubMed ID: 15556120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for bipolar disorder with the Mood Disorders Questionnaire: a review.
    Zimmerman M; Galione JN
    Harv Rev Psychiatry; 2011; 19(5):219-28. PubMed ID: 21916824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dual factor structure of self-rated MDQ hypomania: energized-activity versus irritable-thought racing.
    Benazzi F; Akiskal HS
    J Affect Disord; 2003 Jan; 73(1-2):59-64. PubMed ID: 12507738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
    Møller T; Linaker OM
    Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irritable-hostile depression: further validation as a bipolar depressive mixed state.
    Benazzi F; Akiskal H
    J Affect Disord; 2005 Feb; 84(2-3):197-207. PubMed ID: 15708417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability.
    Goldberg JF; Garno JL; Callahan AM; Kearns DL; Kerner B; Ackerman SH
    J Clin Psychiatry; 2008 Nov; 69(11):1751-7. PubMed ID: 18945397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing new diagnostic criteria for hypomania.
    Benazzi F
    Ann Clin Psychiatry; 2007; 19(2):99-104. PubMed ID: 17612849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.